Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mangoceuticals (MGRX) Non Operating Income (2023 - 2025)

Historic Non Operating Income for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to -$75850.0.

  • Mangoceuticals' Non Operating Income rose 6860.77% to -$75850.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$480410.0, marking a year-over-year decrease of 347.02%. This contributed to the annual value of -$735233.0 for FY2024, which is 1145845.82% down from last year.
  • As of Q3 2025, Mangoceuticals' Non Operating Income stood at -$75850.0, which was up 6860.77% from -$147325.0 recorded in Q2 2025.
  • Over the past 5 years, Mangoceuticals' Non Operating Income peaked at $13700.0 during Q1 2025, and registered a low of -$270935.0 during Q4 2024.
  • Moreover, its 3-year median value for Non Operating Income was -$111587.5 (2025), whereas its average is -$117279.4.
  • Per our database at Business Quant, Mangoceuticals' Non Operating Income crashed by 280470.06% in 2024 and then skyrocketed by 6860.77% in 2025.
  • Quarter analysis of 3 years shows Mangoceuticals' Non Operating Income stood at $8233.0 in 2023, then plummeted by 3390.84% to -$270935.0 in 2024, then surged by 72.0% to -$75850.0 in 2025.
  • Its last three reported values are -$75850.0 in Q3 2025, -$147325.0 for Q2 2025, and $13700.0 during Q1 2025.